Published in Eur J Cancer Clin Oncol on October 01, 1983
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell (1989) 10.98
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene (2000) 4.90
The plasminogen activator/plasmin system. J Clin Invest (1991) 4.20
Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature (1990) 3.46
Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet (1994) 3.10
A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci U S A (1995) 2.70
p53 mutations in BRCA1-associated familial breast cancer. Lancet (1997) 2.69
A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Serv (1997) 2.58
Comparative study of human and rat mammary tumorigenesis. Lab Invest (1990) 2.58
Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet (1994) 2.45
Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J (1995) 2.14
Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res (1982) 2.07
Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med (Berl) (1997) 1.77
Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours. Oncogene (1994) 1.75
Human breast development. J Mammary Gland Biol Neoplasia (2000) 1.71
Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res (1989) 1.64
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res (2000) 1.62
Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study. Plast Reconstr Surg (1994) 1.58
Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor. J Biol Chem (1996) 1.56
Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene (1990) 1.56
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Ann Oncol (2011) 1.49
The molecular pathology of small round-cell tumours--relevance to diagnosis, prognosis, and classification. J Pathol (1996) 1.45
p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Oncogene (1998) 1.41
Additional copies of 1q in sequential samples from a phyllodes tumor of the breast. Cancer Genet Cytogenet (1995) 1.40
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer (1998) 1.40
Increased EGF receptors on human squamous carcinoma cell lines. Br J Cancer (1986) 1.36
Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res (1998) 1.33
Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface. J Cell Biol (1987) 1.33
Improved immunohistochemical localization of tissue antigens using modified methacarn fixation. J Histochem Cytochem (1985) 1.32
Compartment switching of WNT-2 expression in human breast tumors. Cancer Res (1996) 1.32
Locally applied GM-CSF induces the accumulation of alpha-smooth muscle actin containing myofibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 1.31
Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas. Cancer Res (1987) 1.29
Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol (2000) 1.27
Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. Oncogene (1999) 1.26
Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest (1996) 1.25
Trend of burnout among Swiss doctors. Swiss Med Wkly (2010) 1.24
Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast tumours. Oncogene (1995) 1.21
Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis (1997) 1.20
Identification of myoepithelial cells in human and rat breasts by anti-common acute lymphoblastic leukemia antigen antibody A12. J Natl Cancer Inst (1986) 1.20
Characterization in vitro of luminal and myoepithelial cells isolated from the human mammary gland by cell sorting. Differentiation (1991) 1.20
Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol (1993) 1.18
Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene (1996) 1.17
Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J Clin Invest (1994) 1.16
Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up. Hum Pathol (1998) 1.14
Structural alterations of the RB1 gene in human soft tissue tumours. Br J Cancer (1989) 1.14
Cell-surface peptidases as modulators of growth and differentiation. Lancet (1989) 1.13
The development of epithelial phenotypes in the human fetal and infant breast. J Pathol (1998) 1.13
The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells. Tumour Biol (1990) 1.13
Retroviral expression of Wnt-1 and Wnt-7b produces different effects in mouse mammary epithelium. J Cell Sci (2000) 1.12
Invading squamous cell carcinoma can retain a basal lamina. An immunohistochemical study using a monoclonal antibody to type IV collagen. Lab Invest (1984) 1.11
Coronary spasm induced by capecitabine. Ann Oncol (2001) 1.10
Prognostic importance of thymidylate synthase expression in early breast cancer. J Clin Oncol (1997) 1.08
Murine clusterin: molecular cloning and mRNA localization of a gene associated with epithelial differentiation processes during embryogenesis. J Cell Biol (1993) 1.07
Prognostic significance of p53 mutation in breast cancer: frequent detection of non-missense mutations by yeast functional assay. Int J Cancer (1999) 1.07
The kidney is a major site of alpha(2)-antiplasmin production. J Clin Invest (1996) 1.06
Expression of alpha-smooth-muscle actin in stromal cells of the uterine cervix during epithelial neoplastic changes. Int J Cancer (1991) 1.06
An immunocytochemical study of the distribution of epithelial membrane antigen in normal and disordered squamous epithelium. Diagn Histopathol (1982) 1.05
Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas. Br J Cancer (1994) 1.03
Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) in alveolar rhabdomyosarcoma--a diagnostic tool in minimally invasive biopsies. J Pathol (1996) 1.01
Low incidence of ras oncogene activation in human squamous cell carcinomas. Br J Cancer (1990) 1.01
Expression of members of the myf gene family in human rhabdomyosarcomas. Br J Cancer (1991) 1.00
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Ann Oncol (2011) 1.00
Biochemical markers in bronchogenic carcinoma. Br J Dis Chest (1978) 0.99
Purification and partial characterization of high-molecular-weight forms of ectopic calcitonin from a human bronchial carcinoma cell line. Biochem J (1980) 0.99
Plasminogen activator inhibitor-1 is induced in migrating endothelial cells. J Cell Physiol (1992) 0.99
In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells. J Cell Biol (1998) 0.98
Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle. EMBO J (1993) 0.97
Expression of the receptor protein tyrosine kinase myk-1/htk in normal and malignant mammary epithelium. Biochem Biophys Res Commun (1996) 0.97
Pez: a novel human cDNA encoding protein tyrosine phosphatase- and ezrin-like domains. Biochem Biophys Res Commun (1995) 0.97
Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma--a detailed morphological analysis. J Pathol (1990) 0.97
Immunocytochemistry in the identification of vascular invasion in breast cancer. J Clin Pathol (1984) 0.96
Simultaneous demonstration of keratin and mucin. J Histochem Cytochem (1982) 0.96
Acromegaly due to production of a growth hormone releasing factor by a bronchial carcinoid tumor. Clin Endocrinol (Oxf) (1979) 0.96
The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia. Virchows Arch B Cell Pathol Incl Mol Pathol (1990) 0.95
Survival of cultured allografts in patients with burns assessed with probe specific for Y chromosome. BMJ (1989) 0.95
Malignant glioma: should chemotherapy be overthrown by experimental treatments? Ann Oncol (1998) 0.94
Plasminogen activators in the mouse mammary gland. Decreased expression during lactation. J Biol Chem (1989) 0.94
Diagnosis of Ewing's sarcoma and related tumours by detection of chromosome 22q12 translocations using fluorescence in situ hybridization on tumour touch imprints. J Pathol (1995) 0.94
Elevated levels of angiogenic cytokines in the plasma of cancer patients. Int J Cancer (2000) 0.94
Regulation of parathyroid hormone-related protein production in a human lung squamous cell carcinoma line. J Endocrinol (1994) 0.93
High frequency, high resolution B-scan ultrasound in the assessment of skin tumours. Br J Dermatol (1993) 0.93
Excess of hMLH1 germline mutations in Swiss families with hereditary non-polyposis colorectal cancer. Int J Cancer (1998) 0.92
Epithelial markers in the diagnosis of nasopharyngeal carcinoma: an immunocytochemical study. J Clin Pathol (1983) 0.92
Ectoenzyme regulation by phenotypically distinct fibroblast sub-populations isolated from the human mammary gland. J Cell Sci (1994) 0.92
The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome. Oncogene (1994) 0.91
Prenatal factors may influence predisposition to breast cancer. Eur J Cancer (1994) 0.91
Distribution of epithelial membrane antigen in benign and malignant lesions of the salivary glands. Virchows Arch A Pathol Anat Histol (1982) 0.91
Modulation of hepatocyte growth factor and c-met in the rat mammary gland during pregnancy, lactation, and involution. Exp Cell Res (1995) 0.91
Plasmin-catalyzed proteolysis in colorectal neoplasia. Cancer Res (1995) 0.91
Helix pomatia in breast cancer. Lancet (1991) 0.91
Tumor marker production in human bronchial carcinoma xenografts. Oncodev Biol Med (1982) 0.90
A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer. Int J Cancer (2000) 0.89
Markers in breast and lung cancer. Ann Clin Biochem (1982) 0.89
Rat monoclonal antibodies to the external domain of the product of the C-erbB-2 proto-oncogene. Int J Cancer (1990) 0.89
Tumour calcitonin. Interaction with specific calcitonin receptors. Biochem J (1980) 0.89
Characterization of luminal and basal cells flow-sorted from the adult rat mammary parenchyma. J Cell Sci (1991) 0.89
Growth and development of the human infant breast. Am J Anat (1991) 0.89
Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritis. Kidney Int (1995) 0.89